About Jon Slezak, MD
Jon Slezak MD, is an otolaryngologist with BayCare Clinic Ear, Nose & Throat. He practices at Aurora BayCare Medical Center in Green Bay, Wisconsin, and Aurora BayCare Health Center in Kaukauna, Wisconsin.
Related Medical Services
Locations
Aurora BayCare Medical Center - BayCare Clinic Ear, Nose & Throat
Green Bay
Location Details read_more
Aurora BayCare Health Center in Kaukauna - BayCare Clinic Ear, Nose & Throat
Kaukauna
Location Details read_moreMore from Jon Slezak, MD
BayCare Clinic names latest physician partners
Read More read_more
Watch: Dr. Jon Slezak discusses allergies and sinus conditions
Read More read_more
Meet Dr. Jon Slezak, otolaryngologist
Read More read_more
BayCare Clinic in the News: New organs discovered in the throat
Read More read_more
Slezak joins BayCare Clinic Ear, Nose & Throat
Read More read_moreCertifications
Board Certified by the American Board of Otolaryngology - Otolaryngology
Education
2015 University of Wisconsin School of Medicine and Public Health, Madison, WI
Internships
University of Kentucky School of Medicine
Residency
University of Kentucky School of Medicine – Otolaryngology
Professional Associations and Memberships
Truong M, Slezak J, Lin CP, Viacheslav I, Sado M, Razmaria AA, Leverson G, Soloway M, Eggener SE, Abel EJ, Downs T, Jarrard DF. Development and Multi-institutional Validation of an Upgrading Risk Tool for Gleason 6 Prostate Cancer. Cancer, 2013.
Slezak J1, Truong M1, Huang W, and Jarrard DF. Hp1γ is Elevated in Prostate Cancer and is Superior to Gleason Score as a Predictor of Biochemical Recurrence after Radical Prostatectomy. BMC Cancer 23:13(1):138, 2013. 1Equally contributing authors
Truong M, Viacheslav I, Lin CP, Slezak J, Sado M, Razmaria AA, Leverson G, Soloway M, Eggener SE, Abel EJ, Downs T, Jarrard DF. Development and Multi-institutional Validation of Biopsy-Integrated Algorithm for Determining Gleason 6 Upgrading Risk. Journal of Urology 189(4):e274-275, 2013.
Slezak J, Truong M Huang W, and Jarrard DF. Hp1γ is Elevated in Prostate Cancer and is Superior to Gleason Score as a Predictor of Biochemical Recurrence after Radical Prostatectomy. Journal of Urology 189(4):e83, 2013.
Shiau J, Truong M, Slezak J, Abel EJ, Downs T, Jarrard DF. Novel Approach to Risk Stratification in Patients Considering Active Surveillance. Journal of Urology 189(4):e90, 2013